Tissue Sodium in Patients With Psoriasis

The cytokine interleukin-17A (IL-17A) is a crucial player in the pathogenesis of the autoimmune disease of psoriasis. This neutrophil recruiting cytokine is produced by IL-17A producing CD4+ T cells (Th17) and gamma/delta T cells of the skin and evokes an inflammation circuit finally leading to the classical clinical picture of psoriasis with hyper- and parakeratosis, erythema, scaling and neutrophil abscess formation.

Besides genetic factors, lifestyle factors are relevant and decide if an autoimmune disease becomes manifest. It was shown previously that increased salt (sodium chloride, NaCl) concentrations boost the induction of murine and human Th17 cells. However, more - and also clinical - studies are needed to understand the correlation between salt content and IL-17A in autoimmune diseases.

This study investigates the hypothesis if skin sodium content in human psoriasis is increased in order to get further insight into the IL-17A-salt-interplay.

Inclusion criteria

• Age: 18-80
• Body mass index (BMI) 18.5- 40 kg/m2
• Glomerular filtration rate >60 ml/min/1.73m2

Exclusion criteria

• Diagnosed or treated hypertension and/or blood pressure above 140/90 at screening
• Palpable peripheral oedema during phyisical examination at screening
• Any type of diabetes mellitus and/or HgbA1c>6.5% at screening
• Subjects with a thyroid-stimulating hormone >4.2 mU/L at screening
• Psoriasis patients treated with systemic corticosteroids, chemotherapy agent (methothrexate) or with any kind of biologics/biosimilars
• Subjects with acute disease
• Pregnant or lactating women
• Metal or medical device implant in the body
• Tattoo on the lower extremities
• Subjects with a history of drug or alcohol abuse
• Subjects who are legal incapacitated or their circumstances do not enable the patient to fully understand the nature, significance and scope of this study.